TREMFYA® (guselkumab) is the first medication of its kind to be approved by the Food and Drug Administration (FDA) in 2017 to treat adults with moderate to severe plaque psoriasis. In July 2020, the FDA also approved TREMFYA® to treat adults with active psoriatic arthritis.
TREMFYA® has 14+ years of combined clinical research* and 6+ years on the market across indications.
*Based on a clinical trial of TREMFYA® initiated in 2009.
In a study, nearly 7 out of 10 patients with 90% clearer skin at 16 weeks were still clearer at 5 years.
At 1 year and thereafter, patients and healthcare providers knew that TREMFYA® was being used.
This may have increased results. Individual results may vary.
Ask your doctor about the benefits and risks of TREMFYA®. Prescription medications, including TREMFYA®, have possible risks involved with treatment, so it’s important to discuss them with your doctor.
TREMFYA® may cause serious side effects, including:
Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:
These are not all the possible side effects of TREMFYA®.
Please read the Important Safety Information located at the bottom of the screen and the Medication Guide for TREMFYA® to learn more about these and other risks for TREMFYA®. Discuss any questions you have with your doctor.
TREMFYA® may cause serious side effects including:
These are not all the possible side effects of TREMFYA®. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
How often will you need
to take TREMFYA®?
1 injection on day 1
1 injection 4 weeks later
Week 12 & beyond
1 injection every 8 weeks
Not Actual Size
You can take TREMFYA® by using either the One-Press patient-controlled self-injector or a prefilled syringe.
TREMFYA® is a single-dose 100 mg injection taken under the skin at weeks 0 and 4, and then every 8 weeks. That’s only 6 doses per year after 2 starter doses.
TREMFYA® is intended for use under the guidance and supervision of physicians. Patients may self-inject after proper training and physician approval.
Want to know more about dosing with TREMFYA®? Click here.